603739 蔚蓝生物
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.7424.8144.29910.04910.920
总资产报酬率 ROA (%)0.4202.8762.9107.2187.976
投入资产回报率 ROIC (%)0.5153.4813.4558.8969.525

边际利润分析
销售毛利率 (%)44.45546.22743.23146.25548.728
营业利润率 (%)7.89410.2518.84714.84714.794
息税前利润/营业总收入 (%)9.64511.4009.23915.16715.068
净利润/营业总收入 (%)5.9848.5797.34313.04312.737

收益指标分析
经营活动净收益/利润总额(%)57.47185.72486.40678.34283.387
价值变动净收益/利润总额(%)20.36312.7653.4064.4494.337
营业外收支净额/利润总额(%)0.075-0.331-0.7010.312-1.366

偿债能力分析
流动比率 (X)1.0381.0331.5032.6102.721
速动比率 (X)0.8390.8441.2342.1882.264
资产负债率 (%)39.16939.83732.76424.13323.164
带息债务/全部投入资本 (%)28.67127.95422.39710.175--
股东权益/带息债务 (%)241.112249.206336.089848.5414,204.827
股东权益/负债合计 (%)145.342141.336194.654299.252307.574
利息保障倍数 (X)5.5269.63720.36855.57631.861

营运能力分析
应收账款周转天数 (天)100.76693.28484.60768.2290.000
存货周转天数 (天)118.244105.83090.13781.9960.000